Mechanical Heart Valves and Anticoagulation in Pregnancy
On this page
Direct answer
Women with mechanical heart valves need lifelong anticoagulation, and in pregnancy every option carries a risk. Warfarin crosses the placenta and causes warfarin embryopathy when given in the first trimester, while unfractionated or low molecular weight heparin fails more often to prevent valve thrombosis. Guidelines therefore use a trimester-specific regimen that switches between heparin and warfarin, with the exact timing decided by the pregnancy heart team.
What you must remember
- Warfarin embryopathy: nasal hypoplasia, stippled epiphyses and central nervous system abnormalities after exposure in the early weeks, roughly weeks 6 to 12.
- Heparin failure: lower reliability in preventing valve thrombosis, with dose-sensitive effects, which is why heparin is not used throughout pregnancy.
- Preferred mid-pregnancy: warfarin is the agent of choice from about week 12 to week 36, whatever the dose. The 5 mg per day threshold applies to the first trimester, where continuing warfarin is an option if the daily dose is 5 mg or less.
- Late pregnancy: switch to heparin by about 36 weeks, and before delivery so that anticoagulation can be stopped in time.
- Neuraxial anaesthesia: therapeutic low molecular weight heparin is held for about 24 hours, and unfractionated heparin for a shorter period, before neuraxial block.
- Postpartum: warfarin is restarted after delivery, and it is compatible with breastfeeding.
- Bioprosthetic valves: do not need lifelong anticoagulation, which is a key distinction from mechanical valves.
A trimester-specific regimen
A 30-year-old with a mechanical aortic valve plans pregnancy and presents at 7 weeks. The regimen changes at each stage because the risk of warfarin embryopathy and the risk of valve thrombosis peak at different times, so the drug is chosen by gestation rather than kept constant.
| Period | Preferred regimen | Main concern |
|---|---|---|
| Before conception | Plan with the heart team | Stable anticoagulation and counselling |
| About weeks 6 to 12 | Heparin (dose-adjusted), or warfarin continued if dose is 5 mg per day or less after counselling | Embryopathy versus valve thrombosis |
| About weeks 12 to 36 | Warfarin | Monitor INR, avoid fetal bleeding |
| About week 36 to delivery | Switch to heparin | Timing relative to labour and neuraxial block |
| Postpartum | Restart warfarin | Lactation is compatible |
The week boundaries differ between guidelines, and national and society statements vary in detail. Candidates should memorise the logic, which is heparin in early pregnancy to avoid embryopathy (or low-dose warfarin of 5 mg per day or less after counselling), warfarin in mid pregnancy and heparin near term, and confirm the exact cut-offs in the local protocol.
Where the exam tries to catch you
Valve questions test whether the candidate weighs embryopathy against thrombosis, rather than choosing one drug for all trimesters.
- Trap: "Warfarin is safe throughout pregnancy because heparin fails." Correct: warfarin is teratogenic in the early weeks, so heparin is used in the first trimester and warfarin is reintroduced in the middle trimesters.
- Trap: "Mechanical and bioprosthetic valves need the same anticoagulation." Correct: only mechanical valves need lifelong anticoagulation, while bioprosthetic valves generally do not.
- Trap: "Give neuraxial anaesthesia while the woman is on therapeutic heparin." Correct: anticoagulation must be stopped with an appropriate interval before neuraxial block to avoid spinal haematoma.
Frequently asked questions
What is warfarin embryopathy and when does it occur?
Warfarin embryopathy is a pattern of nasal hypoplasia, stippled epiphyses and central nervous system abnormalities after warfarin exposure in the early weeks of pregnancy, roughly weeks 6 to 12. This is why warfarin is avoided in that window in women with mechanical heart valves.
Why is heparin not used throughout pregnancy in mechanical valves?
Heparin is not used throughout pregnancy in mechanical valves because it is less reliable than warfarin in preventing valve thrombosis, a complication known as heparin failure. Warfarin is therefore used in the middle trimesters, when the risk of embryopathy has passed.
When should warfarin be switched to heparin before delivery?
Warfarin is generally switched to heparin around 36 weeks in women with mechanical valves, so that anticoagulation can be stopped in time for labour and neuraxial anaesthesia. Guidelines differ on the exact timing, so the local pregnancy heart team protocol should be followed.
Is warfarin safe during breastfeeding in women with mechanical valves?
Warfarin is generally considered compatible with breastfeeding in women with mechanical valves, which is why it is commonly restarted after delivery. Anticoagulation decisions should be confirmed with the cardiology and haematology team.